Lista de obras - Carsten Saft - Dominio Público Uruguay

"Theory of mind" is impaired in Huntington's disease

artículo científico publicado en 2011

A Prospective Pilot Trial for Pallidal Deep Brain Stimulation in Huntington's Disease.

artículo científico publicado en 2015

A novel cognitive-neurophysiological state biomarker in premanifest Huntington's disease validated on longitudinal data

artículo científico publicado en 2013

A protein quality control pathway regulated by linear ubiquitination

scientific article published on 18 March 2019

A randomized, placebo-controlled trial of AFQ056 for the treatment of chorea in Huntington's disease

artículo científico publicado en 2015

ASK1 and MAP2K6 as modifiers of age at onset in Huntington's disease.

artículo científico publicado en 2008

Action selection in a possible model of striatal medium spiny neuron dysfunction: behavioral and EEG data in a patient with benign hereditary chorea

artículo científico publicado en 2013

Activation of NPY-Y2 receptors ameliorates disease pathology in the R6/2 mouse and PC12 cell models of Huntington's disease.

artículo científico publicado en 2018

Age at onset in Huntington's disease: replication study on the associations of ADORA2A, HAP1 and OGG1.

artículo científico publicado en 2010

Age at onset of Huntington disease is not modulated by the R72P variation in TP53 and the R196K variation in the gene coding for the human caspase activated DNase (hCAD)

artículo científico publicado en 2005

Alterations in voluntary movement execution in Huntington's disease are related to the dominant motor system: evidence from event-related potentials

artículo científico publicado en 2008

Altered ventral striatal activation during reward and punishment processing in premanifest Huntington's disease: a functional magnetic resonance study

artículo científico publicado en 2012

Amisulpride in Huntington's disease

artículo científico publicado en 2005

An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington's disease

artículo científico publicado en 2015

Apolipoprotein E genotypes do not influence the age of onset in Huntington's disease.

artículo científico publicado en 2004

Assessment of complex movements reflects dysfunction in Huntington's disease

artículo científico publicado en 2003

Assessment of simple movements and progression of Huntington's disease

artículo científico publicado en 2007

Assessment of simple movements reflects impairment in Huntington's disease

artículo científico publicado en 2006

Assessment of the Performance of a Modified Motor Scale as Applied to Juvenile Onset Huntington's Disease

artículo científico publicado en 2019

Association of age at onset in Huntington disease with functional promoter variations in NPY and NPY2R.

artículo científico publicado en 2014

Asymmetric anhidrosis in MSA

scientific article published on 01 July 2003

Author Correction: Laquinimod treatment in the R6/2 mouse model

scholarly article published in Scientific Reports

Autonomic nervous system function in Huntington's disease.

artículo científico publicado en 2002

Behavioral and neurophysiological evidence for the enhancement of cognitive control under dorsal pallidal deep brain stimulation in Huntington's disease

artículo científico publicado en 2014

Benign hereditary chorea as an experimental model to investigate the role of medium spiny neurons for response adaptation

artículo científico publicado en 2014

Better global and cognitive functioning in choreatic versus hypokinetic-rigid Huntington's disease

artículo científico publicado en 2013

Brain activation and functional connectivity in premanifest Huntington's disease during states of intrinsic and phasic alertness

artículo científico publicado en 2011

Bupropion for the treatment of apathy in Huntington's disease: A multicenter, randomised, double-blind, placebo-controlled, prospective crossover trial.

artículo científico publicado en 2017

CNR1 variation is associated with the age at onset in Huntington disease

artículo científico publicado en 2013

Cannabinoids for Treatment of Dystonia in Huntington's Disease

artículo científico publicado en 2018

Changes in cognitive control in pre-manifest Huntington's disease examined using pre-saccadic EEG potentials - a longitudinal study

artículo científico publicado en 2014

Chorein-sensitive polymerization of cortical actin and suicidal cell death in chorea-acanthocytosis

artículo científico publicado en 2012

Chronic subdural haematoma in patients with Huntington's disease.

artículo científico publicado en 2006

Clinical and genetic characteristics of late-onset Huntington's disease

artículo científico publicado en 2018

Clinical utility gene card for: Huntington's disease

artículo científico publicado en 2013

Complex movement behaviour and progression of Huntington's disease

artículo científico publicado en 2007

Congruent deterioration of complex and simple movements in patients with Huntington's disease.

artículo científico publicado en 2004

Cross sectional PET study of cerebral adenosine A₁ receptors in premanifest and manifest Huntington's disease

artículo científico publicado en 2014

Default-mode network changes in preclinical Huntington's disease

artículo científico publicado en 2012

Defining pediatric huntington disease: Time to abandon the term Juvenile Huntington Disease ?

Depression in patients with Huntington disease correlates with alterations of the brain stem raphe depicted by transcranial sonography

artículo científico publicado en 2011

Diadochokinetic movements differ between patients with Huntington's disease and controls

artículo científico publicado en 2013

Does arterial hypertension influence the onset of Huntington's disease?

artículo científico publicado en 2018

Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's Disease patients: a case series.

artículo científico publicado en 2006

Echogenicity of basal ganglia structures in different Huntington's disease phenotypes

artículo científico publicado en 2014

Efficacy of fumaric acid esters in the R6/2 and YAC128 models of Huntington's disease

artículo científico publicado en 2011

Error processing in Huntington's disease

artículo científico publicado en 2006

Error processing in normal aging and in basal ganglia disorders.

artículo científico publicado en 2008

Evidence for divergent effects of neurodegeneration in Huntington's disease on attentional selection and neural plasticity: implications for excitotoxicity

artículo científico publicado en 2014

Exploring Genetic Factors Involved in Huntington Disease Age of Onset: E2F2 as a New Potential Modifier Gene.

artículo científico publicado en 2015

Expression of brain-derived neurotrophic factor in astrocytes - Beneficial effects of glatiramer acetate in the R6/2 and YAC128 mouse models of Huntington's disease

artículo científico publicado en 2016

Failure to confirm influence of methyltetrahydrofolate reductase (MTHFR) polymorphisms on age at onset of Huntington disease

artículo científico publicado en 2005

Faster perceptual learning through excitotoxic neurodegeneration

artículo científico publicado en 2012

Functional and structural MRI biomarkers to detect pre-clinical neurodegeneration

artículo científico publicado en 2013

Functional compensation or pathology in cortico-subcortical interactions in preclinical Huntington's disease?

artículo científico publicado en 2007

G15 Switch of cerebral A1 adenosine receptor radioligand binding during phenoconversion of Huntington disease: a PET study

Glutathione S-Transferase Omega 1 variation does not influence age at onset of Huntington's disease

artículo científico publicado en 2004

Hepatic mitochondrial dysfunction in Friedreich ataxia

artículo científico publicado en 2011

Hepatic mitochondrial dysfunction in manifest and premanifest Huntington disease

artículo científico publicado en 2013

High noon back pain- severe pseudoradicular pain as a lead symptom of superficial siderosis: a case report

artículo científico publicado en 2014

Huntington's disease as caused by 34 CAG repeats.

artículo científico publicado en 2008

Hyperhomocysteinaemia in treated patients with Huntington's disease homocysteine in HD.

artículo científico publicado en 2004

Identifying modifiers of Huntington's disease progression

artículo científico publicado en 2017

Impaired motor speech performance in Huntington's disease

artículo científico publicado en 2013

Increase of angiotensin II type 1 receptor auto-antibodies in Huntington's disease

artículo científico publicado en 2014

Increased cognitive functioning in symptomatic Huntington's disease as revealed by behavioral and event-related potential indices of auditory sensory memory and attention.

artículo científico publicado en 2008

Is the retina affected in Huntington disease?

artículo científico publicado en 2005

J10 Neuropathology of the ventral striatum and extended amygdala in huntingon disease

Laquinimod treatment in the R6/2 mouse model

artículo científico publicado en 2017

Levels of error processing in Huntington's disease: a combined study using event-related potentials and voxel-based morphometry.

artículo científico publicado en 2008

Levodopa in plasma correlates with body weight of parkinsonian patients

artículo científico publicado en 2000

Magnetic resonance perfusion imaging of resting-state cerebral blood flow in preclinical Huntington's disease

artículo científico publicado en 2011

Mechanisms mediating parallel action monitoring in fronto-striatal circuits.

artículo científico publicado en 2012

Mentalizing in preclinical Huntington's disease: an fMRI study using cartoon picture stories.

artículo científico publicado en 2013

Methyltetrahydrofolate reductase polymorphism influences onset of Huntington's disease.

artículo científico publicado en 2004

Mitochondrial haplogroup H correlates with ATP levels and age at onset in Huntington disease.

artículo científico publicado en 2010

Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease

artículo científico publicado en 2005

Morbus Huntington - a human genetic model disease

artículo científico publicado en 2000

Music perception and movement deterioration in Huntington’s disease ⬇️

artículo científico publicado el 20 de septiembre de 2011

Mutations in TITF1 are not relevant to sporadic and familial chorea of unknown cause.

artículo científico publicado en 2006

NMDA receptor gene variations as modifiers in Huntington disease: a replication study

artículo científico publicado en 2011

NR2A and NR2B receptor gene variations modify age at onset in Huntington disease

artículo científico publicado en 2004

NR2A and NR2B receptor gene variations modify age at onset in Huntington disease in a sex-specific manner

artículo científico publicado en 2007

Neuroprotective dimethyl fumarate synergizes with immunomodulatory interferon beta to provide enhanced axon protection in autoimmune neuroinflammation

artículo científico publicado en 2014

No association between polymorphisms in the BDNF gene and age at onset in Huntington disease.

artículo científico publicado en 2006

No evidence of impaired gastric emptying in early Huntington's Disease.

artículo científico publicado en 2011

Objective assessment of gait and posture in premanifest and manifest Huntington disease - A multi-center study.

artículo científico publicado en 2018

On the role of fronto-striatal neural synchronization processes for response inhibition--evidence from ERP phase-synchronization analyses in pre-manifest Huntington's disease gene mutation carriers

artículo científico publicado en 2011

Oral and dental health in Huntington's disease - an observational study

artículo científico publicado en 2013

PGC-1alpha as modifier of onset age in Huntington disease

artículo científico publicado en 2009

PGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease.

artículo científico publicado en 2011

Phonatory dysfunction as a preclinical symptom of Huntington disease

artículo científico publicado en 2014

Post pump chorea in a 77-year-old male

artículo científico publicado en 2011

Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial

artículo científico publicado en 2011

Progression of motor subtypes in Huntington's disease: a 6-year follow-up study.

artículo científico publicado en 2016

Progressive hepatic mitochondrial dysfunction in premanifest Huntington's disease

artículo científico publicado en 2014

Progressive spinal cord atrophy in manifest and premanifest Huntington's disease

artículo científico publicado en 2017

Prospective Evaluation of Predictive DNA Testing for Huntington's Disease in a Large German Center.

artículo científico publicado en 2017

Response inhibition in Huntington's disease-a study using ERPs and sLORETA.

artículo científico publicado en 2007

Response inhibition subprocesses and dopaminergic pathways: basal ganglia disease effects

artículo científico publicado en 2009

Severe ultrastructural mitochondrial changes in lymphoblasts homozygous for Huntington disease mutation

artículo científico publicado en 2005

Stimulus-response compatibility in Huntington's disease: a cognitive-neurophysiological analysis

artículo científico publicado en 2008

Striatal disorders dissociate mechanisms of enhanced and impaired response selection - Evidence from cognitive neurophysiology and computational modelling

artículo científico publicado en 2014

Supracubital perineurioma misdiagnosed as carpal tunnel syndrome: case report

artículo científico publicado en 2004

Targeting Huntingtin Expression in Patients with Huntington’s Disease

artículo científico publicado en 2019

Teaching Video NeuroImages: spinal and bulbar muscular atrophy mimicking essential tremor

artículo científico publicado en 2012

The role of the immune system in Huntington's disease

artículo científico

Time processing in Huntington's disease: a group-control study

artículo científico publicado en 2007

Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study.

artículo científico publicado en 2004

Treating the whole body in Huntington's disease

artículo científico publicado en 2015

Two different phenomena in basic motor speech performance in premanifest Huntington disease

artículo científico publicado en 2016

Two different phenomena in basic motor speech performance in premanifest Huntington disease.

artículo científico publicado en 2016

Upper gastrointestinal findings in Huntington's disease: patients suffer but do not complain

artículo científico publicado en 2009

What is influencing the phenotype of the common homozygous polymerase-γ mutation p.Ala467Thr?

artículo científico publicado en 2012

What is the course of Huntington's disease?

artículo científico publicado en 2014

fMRI reveals altered auditory processing in manifest and premanifest Huntington's disease

artículo científico publicado en 2007

β-Defensin Genomic Copy Number Does Not Influence the Age of Onset in Huntington's Disease

artículo científico publicado en 2013

Lista de obras de Carsten Saft

"Theory of mind" is impaired in Huntington's disease

A Prospective Pilot Trial for Pallidal Deep Brain Stimulation in Huntington's Disease.

A novel cognitive-neurophysiological state biomarker in premanifest Huntington's disease validated on longitudinal data

A protein quality control pathway regulated by linear ubiquitination

A randomized, placebo-controlled trial of AFQ056 for the treatment of chorea in Huntington's disease

ASK1 and MAP2K6 as modifiers of age at onset in Huntington's disease.

Action selection in a possible model of striatal medium spiny neuron dysfunction: behavioral and EEG data in a patient with benign hereditary chorea

Activation of NPY-Y2 receptors ameliorates disease pathology in the R6/2 mouse and PC12 cell models of Huntington's disease.

Age at onset in Huntington's disease: replication study on the associations of ADORA2A, HAP1 and OGG1.

Age at onset of Huntington disease is not modulated by the R72P variation in TP53 and the R196K variation in the gene coding for the human caspase activated DNase (hCAD)

Alterations in voluntary movement execution in Huntington's disease are related to the dominant motor system: evidence from event-related potentials

Altered ventral striatal activation during reward and punishment processing in premanifest Huntington's disease: a functional magnetic resonance study

Amisulpride in Huntington's disease

An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington's disease

Apolipoprotein E genotypes do not influence the age of onset in Huntington's disease.

Assessment of complex movements reflects dysfunction in Huntington's disease

Assessment of simple movements and progression of Huntington's disease

Assessment of simple movements reflects impairment in Huntington's disease

Assessment of the Performance of a Modified Motor Scale as Applied to Juvenile Onset Huntington's Disease

Association of age at onset in Huntington disease with functional promoter variations in NPY and NPY2R.

Asymmetric anhidrosis in MSA

Author Correction: Laquinimod treatment in the R6/2 mouse model

Autonomic nervous system function in Huntington's disease.

Behavioral and neurophysiological evidence for the enhancement of cognitive control under dorsal pallidal deep brain stimulation in Huntington's disease

Benign hereditary chorea as an experimental model to investigate the role of medium spiny neurons for response adaptation

Better global and cognitive functioning in choreatic versus hypokinetic-rigid Huntington's disease

Brain activation and functional connectivity in premanifest Huntington's disease during states of intrinsic and phasic alertness

Bupropion for the treatment of apathy in Huntington's disease: A multicenter, randomised, double-blind, placebo-controlled, prospective crossover trial.

CNR1 variation is associated with the age at onset in Huntington disease

Cannabinoids for Treatment of Dystonia in Huntington's Disease

Changes in cognitive control in pre-manifest Huntington's disease examined using pre-saccadic EEG potentials - a longitudinal study

Chorein-sensitive polymerization of cortical actin and suicidal cell death in chorea-acanthocytosis

Chronic subdural haematoma in patients with Huntington's disease.

Clinical and genetic characteristics of late-onset Huntington's disease

Clinical utility gene card for: Huntington's disease

Complex movement behaviour and progression of Huntington's disease

Congruent deterioration of complex and simple movements in patients with Huntington's disease.

Cross sectional PET study of cerebral adenosine A₁ receptors in premanifest and manifest Huntington's disease

Default-mode network changes in preclinical Huntington's disease

Defining pediatric huntington disease: Time to abandon the term Juvenile Huntington Disease ?

Depression in patients with Huntington disease correlates with alterations of the brain stem raphe depicted by transcranial sonography

Diadochokinetic movements differ between patients with Huntington's disease and controls

Does arterial hypertension influence the onset of Huntington's disease?

Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's Disease patients: a case series.

Echogenicity of basal ganglia structures in different Huntington's disease phenotypes

Efficacy of fumaric acid esters in the R6/2 and YAC128 models of Huntington's disease

Error processing in Huntington's disease

Error processing in normal aging and in basal ganglia disorders.

Evidence for divergent effects of neurodegeneration in Huntington's disease on attentional selection and neural plasticity: implications for excitotoxicity

Exploring Genetic Factors Involved in Huntington Disease Age of Onset: E2F2 as a New Potential Modifier Gene.

Expression of brain-derived neurotrophic factor in astrocytes - Beneficial effects of glatiramer acetate in the R6/2 and YAC128 mouse models of Huntington's disease

Failure to confirm influence of methyltetrahydrofolate reductase (MTHFR) polymorphisms on age at onset of Huntington disease

Faster perceptual learning through excitotoxic neurodegeneration

Functional and structural MRI biomarkers to detect pre-clinical neurodegeneration

Functional compensation or pathology in cortico-subcortical interactions in preclinical Huntington's disease?

G15 Switch of cerebral A1 adenosine receptor radioligand binding during phenoconversion of Huntington disease: a PET study

Glutathione S-Transferase Omega 1 variation does not influence age at onset of Huntington's disease

Hepatic mitochondrial dysfunction in Friedreich ataxia

Hepatic mitochondrial dysfunction in manifest and premanifest Huntington disease

High noon back pain- severe pseudoradicular pain as a lead symptom of superficial siderosis: a case report

Huntington's disease as caused by 34 CAG repeats.

Hyperhomocysteinaemia in treated patients with Huntington's disease homocysteine in HD.

Identifying modifiers of Huntington's disease progression

Impaired motor speech performance in Huntington's disease

Increase of angiotensin II type 1 receptor auto-antibodies in Huntington's disease

Increased cognitive functioning in symptomatic Huntington's disease as revealed by behavioral and event-related potential indices of auditory sensory memory and attention.

Is the retina affected in Huntington disease?

J10 Neuropathology of the ventral striatum and extended amygdala in huntingon disease

Laquinimod treatment in the R6/2 mouse model

Levels of error processing in Huntington's disease: a combined study using event-related potentials and voxel-based morphometry.

Levodopa in plasma correlates with body weight of parkinsonian patients

Magnetic resonance perfusion imaging of resting-state cerebral blood flow in preclinical Huntington's disease

Mechanisms mediating parallel action monitoring in fronto-striatal circuits.

Mentalizing in preclinical Huntington's disease: an fMRI study using cartoon picture stories.

Methyltetrahydrofolate reductase polymorphism influences onset of Huntington's disease.

Mitochondrial haplogroup H correlates with ATP levels and age at onset in Huntington disease.

Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease

Morbus Huntington - a human genetic model disease

Music perception and movement deterioration in Huntington’s disease ⬇️